ADPT

ADAPTIVE BIOTECHNOLOGIES CORP

Healthcare | Mid Cap

-$0.13

EPS Forecast

$66.85

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.13

Revenue Forecast:

$66.85

EPS Surprise Forecast:

$0.024

Revenue Surprise Forecast:

$5

Post-release price volatility - High

Post-release Overnight Move:

±9.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

75%

Probability of beating revenue consensus:

86%

Probability of beating both EPS & revs consensus:

68%

Probability of missing both EPS & revs consensus:

6%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

1.66

Earnings volatility

EPS standard deviation:

$0.08

Revenue standard deviation:

$9

As % of share price:

0.62% MEDIUM

As % of market cap:

0.44% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.02

Revenue 95th %ile:

$78

EPS 75th %ile:

-$0.10

Revenue 75th %ile:

$70

EPS 25th %ile:

-$0.15

Revenue 25th %ile:

$64

EPS 5th %ile:

-$0.22

Revenue 5th %ile:

$57

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

39% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

54% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$20

Bid-ask per Share:

$0.03